{"transactions":[{"id":10080,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T16:10:08.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":46566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029."}],"balance_after":46566,"derivative":{"exercise_price":113.15,"exercise_date":"2027-05-05","expiration_date":"2036-05-04","underlying":"Common Stock","underlying_shares":46566},"source":{"system":"sec-edgar","filing":"0000310158-26-000135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000135/form4.xml","form_type":"4"}},{"id":10079,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-07T16:10:08.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":15908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029."}],"balance_after":15908,"derivative":{"exercise_date":"2027-05-05","expiration_date":"2029-05-05","underlying":"Common Stock","underlying_shares":15908},"source":{"system":"sec-edgar","filing":"0000310158-26-000135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000135/form4.xml","form_type":"4"}},{"id":10405,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-01T21:39:32.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":false,"shares":3935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028."}],"balance_after":7870,"derivative":{"exercise_date":"2026-04-29","expiration_date":"2028-04-29","underlying":"Common Stock","underlying_shares":3935},"source":{"system":"sec-edgar","filing":"0000310158-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000082/form4.xml","form_type":"4"}},{"id":10404,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-05-01T21:39:32.000Z","date":"2026-04-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1938,"price":110.03,"value":213238.14,"ownership":{"direct":true},"balance_after":92300.657,"source":{"system":"sec-edgar","filing":"0000310158-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000082/form4.xml","form_type":"4"}},{"id":10403,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-05-01T21:39:32.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":true,"shares":3935,"price":110.03,"value":432968.05,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":94238.657,"source":{"system":"sec-edgar","filing":"0000310158-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000082/form4.xml","form_type":"4"}},{"id":310914,"issuer":{"id":116,"kind":"organization","name":"VERIZON COMMUNICATIONS INC","symbol":"VZ"},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2026-04-02T19:59:53.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":5062,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes phantom stock acquired through dividend reinvestment."}],"balance_after":11402,"derivative":{"underlying":"Common Stock","underlying_shares":5062},"source":{"system":"sec-edgar","filing":"0001854928-26-000002","document":"wk-form4_1775159990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/732712/000185492826000002/wk-form4_1775159990.xml","form_type":"4"}},{"id":14563,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-06T21:13:42.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":false,"shares":41997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019."}],"balance_after":0,"derivative":{"exercise_price":53.06,"exercise_date":"2017-05-10","expiration_date":"2026-05-09","underlying":"Common Stock","underlying_shares":41997},"source":{"system":"sec-edgar","filing":"0000310158-26-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000038/form4.xml","form_type":"4"}},{"id":14562,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-02-06T21:13:42.000Z","date":"2026-02-04","kind":"sale","planned":false,"acquired":false,"shares":41997,"price":119.6112,"value":5023311.5664,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.5400 to $119.7800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote."}],"balance_after":90192.194,"source":{"system":"sec-edgar","filing":"0000310158-26-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000038/form4.xml","form_type":"4"}},{"id":14561,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-02-06T21:13:42.000Z","date":"2026-02-04","kind":"exercise","planned":false,"acquired":true,"shares":41997,"price":53.06,"value":2228360.82,"ownership":{"direct":true},"balance_after":132189.194,"source":{"system":"sec-edgar","filing":"0000310158-26-000038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000038/form4.xml","form_type":"4"}},{"id":15072,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2026-01-28T21:10:59.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":15852,"price":107.4,"value":1702504.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/23. Performance shares were paid out at 94 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2025."}],"balance_after":90192.194,"source":{"system":"sec-edgar","filing":"0000310158-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000018/form4.xml","form_type":"4"}},{"id":24642,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-01T22:15:09.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":53735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028."}],"balance_after":53735,"derivative":{"exercise_price":84.71,"exercise_date":"2026-04-29","expiration_date":"2035-04-28","underlying":"Common Stock","underlying_shares":53735},"source":{"system":"sec-edgar","filing":"0001127602-25-013055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760225013055/form4.xml","form_type":"4"}},{"id":24641,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-05-01T22:15:09.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":11805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028."}],"balance_after":11805,"derivative":{"exercise_date":"2026-04-29","expiration_date":"2028-04-29","underlying":"Common Stock","underlying_shares":11805},"source":{"system":"sec-edgar","filing":"0001127602-25-013055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760225013055/form4.xml","form_type":"4"}},{"id":323779,"issuer":{"id":116,"kind":"organization","name":"VERIZON COMMUNICATIONS INC","symbol":"VZ"},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2025-03-20T18:56:54.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes phantom stock acquired through dividend reinvestment."}],"balance_after":5948,"derivative":{"underlying":"Common Stock","underlying_shares":4748},"source":{"system":"sec-edgar","filing":"0001062993-25-005972","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/732712/000106299325005972/form4.xml","form_type":"4"}},{"id":29619,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2025-01-29T23:21:12.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":23432,"price":97.94,"value":2294930.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/22. Performance shares were paid out at 169 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2024."}],"balance_after":74340.194,"source":{"system":"sec-edgar","filing":"0001127602-25-002349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760225002349/form4.xml","form_type":"4"}},{"id":330242,"issuer":{"id":116,"kind":"organization","name":"VERIZON COMMUNICATIONS INC","symbol":"VZ"},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2024-10-03T11:52:25.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":1161,"price":45.21,"value":52488.81,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash.  The shares of phantom stock become payable following the reporting person's termination of service as a director."}],"balance_after":1161,"derivative":{"underlying":"Common Stock","underlying_shares":1161},"source":{"system":"sec-edgar","filing":"0001062993-24-017352","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/732712/000106299324017352/form4.xml","form_type":"4"}},{"id":41529,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T20:07:21.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":49805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027."}],"balance_after":49805,"derivative":{"exercise_price":129.22,"exercise_date":"2025-04-30","expiration_date":"2034-04-29","underlying":"Common Stock","underlying_shares":49805},"source":{"system":"sec-edgar","filing":"0001127602-24-013922","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224013922/form4.xml","form_type":"4"}},{"id":46187,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T21:03:47.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":38291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested and became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018."}],"balance_after":0,"derivative":{"exercise_price":58.08,"exercise_date":"2016-05-01","expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":38291},"source":{"system":"sec-edgar","filing":"0001127602-24-005196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224005196/form4.xml","form_type":"4"}},{"id":46186,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2024-02-15T21:03:47.000Z","date":"2024-02-14","kind":"sale","planned":false,"acquired":false,"shares":38291,"price":125.5,"value":4805520.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.5000 to $125.5050, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":50908.194,"source":{"system":"sec-edgar","filing":"0001127602-24-005196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224005196/form4.xml","form_type":"4"}},{"id":46185,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2024-02-15T21:03:47.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":38291,"price":58.08,"value":2223941.28,"ownership":{"direct":true},"balance_after":89199.194,"source":{"system":"sec-edgar","filing":"0001127602-24-005196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224005196/form4.xml","form_type":"4"}},{"id":48119,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2024-01-24T21:03:40.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":19208,"price":119.43,"value":2294011.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":50908.194,"source":{"system":"sec-edgar","filing":"0001127602-24-002011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224002011/form4.xml","form_type":"4"}},{"id":56290,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T22:29:24.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":58783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026."}],"balance_after":58783,"derivative":{"exercise_price":117.89,"exercise_date":"2024-05-02","expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":58783},"source":{"system":"sec-edgar","filing":"0001127602-23-014574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223014574/form4.xml","form_type":"4"}},{"id":56371,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-05-03T20:07:10.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023."}],"balance_after":0,"derivative":{"exercise_date":"2021-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":866},"source":{"system":"sec-edgar","filing":"0001127602-23-014238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223014238/form4.xml","form_type":"4"}},{"id":56370,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2023-05-03T20:07:10.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":427,"price":115.47,"value":49305.69,"ownership":{"direct":true},"balance_after":31691.269,"source":{"system":"sec-edgar","filing":"0001127602-23-014238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223014238/form4.xml","form_type":"4"}},{"id":56369,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2023-05-03T20:07:10.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":866,"price":115.47,"value":99997.02,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":32118.269,"source":{"system":"sec-edgar","filing":"0001127602-23-014238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223014238/form4.xml","form_type":"4"}},{"id":60025,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2023-01-25T21:48:15.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":2656,"price":109.88,"value":291841.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/20. Performance shares were paid out at 110 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":30186.6811,"source":{"system":"sec-edgar","filing":"0001127602-23-002204","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223002204/form4.xml","form_type":"4"}},{"id":66592,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-05T21:09:35.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":53398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025."}],"balance_after":53398,"derivative":{"exercise_price":87.1,"exercise_date":"2023-05-03","expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":53398},"source":{"system":"sec-edgar","filing":"0001127602-22-013524","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222013524/form4.xml","form_type":"4"}},{"id":66675,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-05-04T21:54:16.000Z","date":"2022-05-03","kind":"exercise","acquired":false,"shares":773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-03","expiration_date":"2022-05-03","underlying":"Common Stock","underlying_shares":773},"source":{"system":"sec-edgar","filing":"0001127602-22-013286","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222013286/form4.xml","form_type":"4"}},{"id":66674,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2022-05-04T21:54:16.000Z","date":"2022-05-03","kind":"tax_withholding","acquired":false,"shares":373,"price":87.65,"value":32693.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":27426.2881,"source":{"system":"sec-edgar","filing":"0001127602-22-013286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222013286/form4.xml","form_type":"4"}},{"id":66673,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2022-05-04T21:54:16.000Z","date":"2022-05-03","kind":"exercise","acquired":true,"shares":773,"price":87.65,"value":67753.45,"ownership":{"direct":true},"balance_after":27799.2881,"source":{"system":"sec-edgar","filing":"0001127602-22-013286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222013286/form4.xml","form_type":"4"}},{"id":66797,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-05-03T20:22:58.000Z","date":"2022-05-01","kind":"exercise","acquired":false,"shares":866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."}],"balance_after":866,"derivative":{"exercise_date":"2021-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":866},"source":{"system":"sec-edgar","filing":"0001127602-22-013030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222013030/form4.xml","form_type":"4"}},{"id":66796,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2022-05-03T20:22:58.000Z","date":"2022-05-01","kind":"tax_withholding","acquired":false,"shares":427,"price":88.69,"value":37870.63,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":27026.2881,"source":{"system":"sec-edgar","filing":"0001127602-22-013030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222013030/form4.xml","form_type":"4"}},{"id":66795,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2022-05-03T20:22:58.000Z","date":"2022-05-01","kind":"exercise","acquired":true,"shares":866,"price":88.69,"value":76805.54,"ownership":{"direct":true},"balance_after":27453.2881,"source":{"system":"sec-edgar","filing":"0001127602-22-013030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222013030/form4.xml","form_type":"4"}},{"id":69945,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2022-02-28T21:27:00.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":2429,"price":73.51,"value":178555.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/19. Performance shares were paid out at 140 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":26555.8061,"source":{"system":"sec-edgar","filing":"0001127602-22-007023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222007023/form4.xml","form_type":"4"}},{"id":77630,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:22:54.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":22683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in equal installments on 5/2/2015, 5/2/2016 and 5/2/2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. (\"Organon\") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the \"Form 10\"). As reported in the Form 10, all Merck stock option awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments."}],"balance_after":0,"derivative":{"exercise_price":56.49,"exercise_date":"2015-05-02","expiration_date":"2024-05-01","underlying":"Common Stock","underlying_shares":22683},"source":{"system":"sec-edgar","filing":"0001127602-21-028467","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028467/form4.xml","form_type":"4"}},{"id":77629,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-11-05T20:22:54.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":18335,"price":91.001,"value":1668503.335,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.0000 to $91.0050, inclusive. The reporting person undertakes to provide to Merck & Co., Inc.,\nany security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this\nfootnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":24113.7671,"source":{"system":"sec-edgar","filing":"0001127602-21-028467","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028467/form4.xml","form_type":"4"}},{"id":77628,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-11-05T20:22:54.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":22683,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42448.7671,"source":{"system":"sec-edgar","filing":"0001127602-21-028467","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221028467/form4.xml","form_type":"4"}},{"id":88488,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-05-06T21:01:17.000Z","date":"2021-05-04","kind":"exercise","acquired":false,"shares":1039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021."}],"balance_after":0,"derivative":{"exercise_date":"2019-05-04","expiration_date":"2021-05-04","underlying":"Common Stock","underlying_shares":1039},"source":{"system":"sec-edgar","filing":"0001127602-21-015766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015766/form4.xml","form_type":"4"}},{"id":88487,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-06T21:01:17.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":67347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024."}],"balance_after":67347,"derivative":{"exercise_price":75.99,"exercise_date":"2022-05-04","expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":67347},"source":{"system":"sec-edgar","filing":"0001127602-21-015766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015766/form4.xml","form_type":"4"}},{"id":88486,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-05-06T21:01:17.000Z","date":"2021-05-04","kind":"tax_withholding","acquired":false,"shares":489,"price":75.98,"value":37154.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":19741.1241,"source":{"system":"sec-edgar","filing":"0001127602-21-015766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015766/form4.xml","form_type":"4"}},{"id":88485,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-05-06T21:01:17.000Z","date":"2021-05-04","kind":"exercise","acquired":true,"shares":1039,"price":75.98,"value":78943.22,"ownership":{"direct":true},"balance_after":20230.1241,"source":{"system":"sec-edgar","filing":"0001127602-21-015766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015766/form4.xml","form_type":"4"}},{"id":88921,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-05-04T21:01:16.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022."}],"balance_after":750,"derivative":{"exercise_date":"2020-05-03","expiration_date":"2022-05-03","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001127602-21-015269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/form4.xml","form_type":"4"}},{"id":88920,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-05-04T21:01:16.000Z","date":"2021-05-01","kind":"exercise","acquired":false,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023."}],"balance_after":1680,"derivative":{"exercise_date":"2021-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001127602-21-015269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/form4.xml","form_type":"4"}},{"id":88919,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-05-04T21:01:16.000Z","date":"2021-05-03","kind":"tax_withholding","acquired":false,"shares":353,"price":74.5,"value":26298.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":19191.1241,"source":{"system":"sec-edgar","filing":"0001127602-21-015269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/form4.xml","form_type":"4"}},{"id":88918,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-05-04T21:01:16.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":750,"price":74.5,"value":55875.0,"ownership":{"direct":true},"balance_after":19544.1241,"source":{"system":"sec-edgar","filing":"0001127602-21-015269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/form4.xml","form_type":"4"}},{"id":88917,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-05-04T21:01:16.000Z","date":"2021-05-01","kind":"tax_withholding","acquired":false,"shares":288,"price":74.5,"value":21456.0,"ownership":{"direct":true},"balance_after":18794.1241,"source":{"system":"sec-edgar","filing":"0001127602-21-015269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/form4.xml","form_type":"4"}},{"id":88916,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10862,"kind":"person","name":"Litchfield Caroline","position":1,"cik":"0001854928","reported_name":"Litchfield Caroline","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2021-05-04T21:01:16.000Z","date":"2021-05-01","kind":"exercise","acquired":true,"shares":840,"price":74.5,"value":62580.0,"ownership":{"direct":true},"balance_after":19082.1241,"source":{"system":"sec-edgar","filing":"0001127602-21-015269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221015269/form4.xml","form_type":"4"}}]}